Edberg JC - Search Results

1

End-stage renal disease in African Americans with lupus nephritis is associated with APOL1.

Freedman BI, Langefeld CD, Andringa KK, Croker JA, Williams AH, Garner NE, Birmingham DJ, Hebert LA, Hicks PJ, Segal MS, Edberg JC, Brown EE, Alarcón GS, Costenbader KH, Comeau ME, Criswell LA, Harley JB, James JA, Kamen DL, Lim SS, Merrill JT, Sivils KL, Niewold TB, Patel NM, Petri M, Ramsey-Goldman R, Reveille JD, Salmon JE, Tsao BP, Gibson KL, Byers JR, Vinnikova AK, Lea JP, Julian BA, Kimberly RP; Lupus Nephritis–End‐Stage Renal Disease Consortium. Freedman BI, et al. Among authors: edberg jc. Arthritis Rheumatol. 2014 Feb;66(2):390-6. doi: 10.1002/art.38220. Arthritis Rheumatol. 2014. PMID: 24504811 Free PMC article.

2

Differential Regulation of Fcgamma Receptor Isoforms: Implications for Therapeutic Intervention.

Chang DJ, Siegel ME, Moon JJ, Edberg JC, Salmon JE, Kimberly RP. Chang DJ, et al. Among authors: edberg jc. Am J Ther. 1995 Oct;2(10):777-781. doi: 10.1097/00045391-199510000-00008. Am J Ther. 1995. PMID: 11854786

3

Genetic linkage and association of Fcgamma receptor IIIA (CD16A) on chromosome 1q23 with human systemic lupus erythematosus.

Edberg JC, Langefeld CD, Wu J, Moser KL, Kaufman KM, Kelly J, Bansal V, Brown WM, Salmon JE, Rich SS, Harley JB, Kimberly RP. Edberg JC, et al. Arthritis Rheum. 2002 Aug;46(8):2132-40. doi: 10.1002/art.10438. Arthritis Rheum. 2002. PMID: 12209518 Free article.

4

A novel polymorphic CAAT/enhancer-binding protein beta element in the FasL gene promoter alters Fas ligand expression: a candidate background gene in African American systemic lupus erythematosus patients.

Wu J, Metz C, Xu X, Abe R, Gibson AW, Edberg JC, Cooke J, Xie F, Cooper GS, Kimberly RP. Wu J, et al. Among authors: edberg jc. J Immunol. 2003 Jan 1;170(1):132-8. doi: 10.4049/jimmunol.170.1.132. J Immunol. 2003. PMID: 12496392

5

A novel polymorphism in the Fcgamma receptor IIB (CD32B) transmembrane region alters receptor signaling.

Li X, Wu J, Carter RH, Edberg JC, Su K, Cooper GS, Kimberly RP. Li X, et al. Among authors: edberg jc. Arthritis Rheum. 2003 Nov;48(11):3242-52. doi: 10.1002/art.11313. Arthritis Rheum. 2003. PMID: 14613290 Free article.

6

A promoter haplotype of the immunoreceptor tyrosine-based inhibitory motif-bearing FcgammaRIIb alters receptor expression and associates with autoimmunity. I. Regulatory FCGR2B polymorphisms and their association with systemic lupus erythematosus.

Su K, Wu J, Edberg JC, Li X, Ferguson P, Cooper GS, Langefeld CD, Kimberly RP. Su K, et al. Among authors: edberg jc. J Immunol. 2004 Jun 1;172(11):7186-91. doi: 10.4049/jimmunol.172.11.7186. J Immunol. 2004. PMID: 15153543

7

The influence of genetic variation in the HLA-DRB1 and LTA-TNF regions on the response to treatment of early rheumatoid arthritis with methotrexate or etanercept.

Criswell LA, Lum RF, Turner KN, Woehl B, Zhu Y, Wang J, Tiwari HK, Edberg JC, Kimberly RP, Moreland LW, Seldin MF, Bridges SL Jr. Criswell LA, et al. Among authors: edberg jc. Arthritis Rheum. 2004 Sep;50(9):2750-6. doi: 10.1002/art.20469. Arthritis Rheum. 2004. PMID: 15457442 Free article.

8

Time to renal disease and end-stage renal disease in PROFILE: a multiethnic lupus cohort.

Alarcón GS, McGwin G Jr, Petri M, Ramsey-Goldman R, Fessler BJ, Vilá LM, Edberg JC, Reveille JD, Kimberly RP; PROFILE Study Group. Alarcón GS, et al. Among authors: edberg jc. PLoS Med. 2006 Oct;3(10):e396. doi: 10.1371/journal.pmed.0030396. PLoS Med. 2006. PMID: 17076550 Free PMC article.

9

Association of a transmembrane polymorphism of Fcgamma receptor IIb (FCGR2B) with systemic lupus erythematosus in Taiwanese patients.

Chen JY, Wang CM, Ma CC, Luo SF, Edberg JC, Kimberly RP, Wu J. Chen JY, et al. Among authors: edberg jc. Arthritis Rheum. 2006 Dec;54(12):3908-17. doi: 10.1002/art.22220. Arthritis Rheum. 2006. PMID: 17133600 Free article.

10

FcalphaRI (CD89) alleles determine the proinflammatory potential of serum IgA.

Wu J, Ji C, Xie F, Langefeld CD, Qian K, Gibson AW, Edberg JC, Kimberly RP. Wu J, et al. Among authors: edberg jc. J Immunol. 2007 Mar 15;178(6):3973-82. doi: 10.4049/jimmunol.178.6.3973. J Immunol. 2007. PMID: 17339498 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

187 results

Search Page

Filters